How Can We Live Longer?
CC-Transcript
00:00We spend so much time talking about this and I wonder what's making you invest in it now? Why are we all so consumed with our own mortality? Well, as people all get older, they generally want to live longer. Most people do. I think it's all it's been going on for a millennium. But now we have the ability with medications and pharmaceutical products and lifestyle changes to actually affect how long we live. So in the year, let's say 400,000 years ago, when humans were coming out of caves as Homo sapiens, the life expectancy was 20. Today, in the United States, the life expectancy is roughly 77. But somebody born today from a good zip code, good ethnicity can probably live to 85 to 90. But people today who are already in their 56 years and seventies, what they want to do is live longer. And it's possible now because of drugs, more knowledge about weight, more knowledge about pharmaceuticals, more knowledge about so many different lifestyle changes that one could adopt that you can live longer. And so this series is about how people can affect the time that they spend on the face of the earth. So that's what it's all about. We selected that clip on GLP one, which has been such a fascinating story over the past couple of years. David A cure all. If you ask certain people, everything from fatty liver to diabetes to obesity to sleep apnea. Have we ever seen something like this that's been approved for so many things? And to what extent does this advance our conversation about advancing our age? Well, we all remember when school that penicillin was discovered as an accident and we later learned that penicillin turned out to be one of the great miracle drugs of all time and saved many, many lives, of course, around the world and still does. GLP one drugs were originally designed to deal with diabetes and the effects of diabetes. But it turns out that they have more significant effects in just dealing with diabetes. They can also make you lose a fair amount of weight, you know, in a way that's responsible. But also they can probably extend your life. And now more and more research is being done to see that the show that GLP one drugs can probably save you many, many years on the face of the earth. You can live longer. And so many, many doctors are now beginning to prescribe it not just for obesity but for other related things that people can can deal with. You're no stranger to politics, of course, David Rubenstein. And I'm wondering if it's possible in this political climate we're in to talk about health in an era when Donald Trump is talking about Marjo and RFK jr is questioning certain sciences. If it's possible to talk about our health without bumping into politics. Well, in Washington, D.C., everything revolves around politics to some extent. But yeah, generally the most important thing I think we should recognize is that the purpose of government is to promote the general welfare. That's what it says in our Constitution and what promotes the general welfare better than helping people to live longer and living healthier. And that's what health is all about. We have the finest medications in the United States, the finest health care in the United States. We just to make sure that people are get access to it. And that's what the debate often is about in Washington. Who's going to get access to the health care and how much are they going to pay for it? But what I'm trying to do with this series is just make be sure people realize that it is possible through changing your lifestyle. They're taking some medications you can live longer than you otherwise would live. And that's something that generally people all over the world want to do more than anything else. People want to have a happy life, a healthy life and a longer life. Yeah, well, it's pretty remarkable how simple that is. And you wonder what happens to GLP one's what else they could be approved for if there's an oral version or so forth. But, David, there's a lot of debate in Washington right now about a number of things, including pharmaceuticals, including whether they should be tariffs. As I said at the beginning of our conversation here, and I have to ask you about the way the market is looking at all of this, because you're David Rubenstein, when you see the markets continuing to see new highs in the face of such uncertainty as we've been told. What do you make of this moment, the psychology in the markets, knowing that August 1st is less than two weeks away? Is this market more sophisticated, a better sense of what's real and what's noise than the political class in Washington? Well, the market generally is a pretty good indicator what people are thinking. As a general rule of thumb. I think most CEOs and most large companies today do not know what the impact of tariffs is going to be going to be. And so it really hasn't factored in that much yet. Most companies, many of the companies that my own firm has under our control don't yet see the need to raise prices to deal with the tariffs because the tariffs aren't yet solidified in terms of what they're going to be. But I think most people in the market generally think that tariffs will be tolerable and probably some price is going to be passed along and maybe some others can't. But I don't think most people feel that the tariffs are now a barrier to continued economic growth. That's fascinating. How about the idea of Donald Trump as chairman of the board, having seen him make moves on specific companies? We'll take a look at what he said about Tim Cook, for instance, at Apple. It's time to move your manufacturing here, and I need you to do it by this date. David is the co-founder of Carlisle. How should board members or people in the C-suite prepare for that type of environment? Well, there is a manufacturing deficit now in the United States. There's no doubt that manufacturing has moved offshore over the last 20 to 30 years because it's very efficient to manufacture things at lower prices offshore. There's no doubt that many CEOs are now beginning to onshore some manufacturing. But we have to be realistic about it. It takes many, many years to build the manufacturing facilities, the United States. So it may be some time before much manufacture is going to come back here. But I suspect some companies are going to manufacture some things in the United States they otherwise would not. But some are going to give lip service to it and some are not really going to pay that much attention to it. In the end, I suspect there will be more manufacturing in the United States three or four years from now than there is today, but a lot less than there was 20 or 30 years ago.
For YouLive TV
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
41 minutes ago
- News24
Should pharmaceutical advertising in SA be better regulated, and why?
Anyone who has travelled to the United States will have been struck by the extent to which medicines, both those requiring a prescription and those that can be bought by consumers without a prescription, are advertised on television. The situation in South Africa is quite different. While there are many advertisements for medicines shown on local television stations, only some are specific about the proprietary (brand) name of the medicine and its indications. Other advertisements focus instead on the indication (the reason for using the medicine), but do not identify it by name. Instead, viewers are urged to approach their pharmacies or medical practitioners. At a different time, an advertisement may be flighted which identifies a medicine, its strength, pack size and perhaps price, but provides no information about what the indication for the medicine is. To what extent does this represent meaningful and justified regulatory control over pharmaceutical marketing? Only two countries with effective medicines regulatory systems allow prescription-only medicines to be advertised directly to the consumer, these being the United States and New Zealand. Other countries, including South Africa, restrict the advertising of prescription-only medicines to the health professionals who can prescribe or dispense them. READ | #InsideTheBox with Dr Andy Gray | Who can prescribe medicines in SA? One of the key justifications for this restriction on the ability of the pharmaceutical industry to market their products is that direct-to-consumer advertising may result in more inappropriate prescribing, when prescribers are under pressure from patients demanding medicines they have seen advertised. Short television advertisements are unlikely to be able to convey a balanced account of the potential benefits and harms of medicines, especially those that are new to the market. South African law contains an interesting variant to regulation in this area. General Regulation 42 issued in terms of the Medicines and Related Substances Act, 1965, allows medicines containing substances in schedules 0 and 1 to be advertised to the public, but requires that those containing substances in schedules 2 to 6 to be advertised 'only for the information of pharmacists, medical practitioners, dentists, veterinarians, practitioners and other authorised prescribers' or 'in a publication which is normally or only made available' to such persons. While Schedule 0 medicines can be bought in any retail outlet, Schedule 1 and 2 medicines can only be obtained from a pharmacy but not self-selected from a shelf. The justification for that particular cut-off is difficult to trace in any policy document. An amendment to the regulation was published for comment in February 2023, but the final regulation has yet to be issued by the minister of health. 'Failure to follow through' The fundamental problem, however, lies in a failure to follow through on the legislation previously passed by Parliament. Section 18C of the current version of the Medicines and Related Substances Act, 1965, contains a prescriptive instruction to the minister. 'The minister shall, after consultation with the relevant industries and other stakeholders, make regulations relating to the marketing of medicines, medical devices or IVDs and such regulations shall also provide for codes of practice for relevant industries,' it states. From 2003 to 2017, the section read: 'The minister shall, after consultation with the pharmaceutical industry and other stakeholders, make regulations relating to the marketing of medicines, and such regulations shall also provide for an enforceable code of practice.' The expansion of the remit to include medical devices and in vitro diagnostics (IVDs) was added by Parliament in 2008 but only took effect in 2017. READ | #InsideTheBox with Dr Andy Gray | Are clinical trial participants in South Africa protected? The wording is peremptory – the minister 'shall' – which leaves no room for delay. While the word 'enforceable' has been removed, the very intent of a regulation is that it should be enforced. That no regulations have been forthcoming in more than 20 years is an extraordinary failure of governance. That failure is compounded by another act of omission. Section 18A of the act states: 'No person shall supply any medicine, medical device or IVD according to a bonus system, rebate system or any other incentive scheme.' The law also enables the minister to 'prescribe acceptable and prohibited acts' in this regard, in consultation with the Pricing Committee. No final regulations have been issued since 2017. The Pricing Committee is established to advise the minister on matters relating to the pricing of medicines, such as the annual maximum increase and the dispensing fees charged by pharmacists and licensed dispensing practitioners. It is already an offence, in terms of Section 29 of the act, for any person to make 'any false or misleading statement in connection with any medicine, scheduled substance, medical device or IVD'. Regulation 42 also states: 'No advertisement for a medicine may contain a statement which deviates from, with or goes beyond the evidence submitted in the application for registration of such medicine with regard to its safety, quality or efficacy where such evidence has been accepted by the authority in respect of such medicine and incorporated into the approved information of such medicine'. While these two provisions may prevent false or misleading advertising, they are limited in their scope. In particular, since no complementary medicines are yet registered by the South African Health Products Regulatory Authority (SAHPRA), none have an approved professional information (previously known as a package insert) or a patient information leaflet. Industry self-regulation The pharmaceutical and medical devices industries have not been idle during this period of government inaction. A non-profit, self-regulatory body, the Marketing Code Authority (MCA), has developed a Code of Marketing Practice, drawing on international guidelines. This code provides for sanctions when rules are broken, following adjudication of a complaint. Fines of up to a maximum of R500 000 can be levied for severe or serious offences, which would, for example, pose 'safety implications for patients'. However, as a self-regulatory body, the MCA cannot require membership by any licensed manufacturer. It means that those manufacturers which are not members of the MCA are not bound by the code and cannot be sanctioned. The MCA therefore advocates that compliance with a code should be a condition to get a licence to operate as a manufacturer. The MCA has also responded to draft regulations on perverse incentives. At a time when deliberate disinformation is being disseminated from many quarters, including from government authorities previously considered to be reliable, a weakened regulatory system cannot simply be allowed to stagger along, in defiance of the express instructions of the legislature. Public safety demands an effective regulatory mechanism to proactively examine pharmaceutical marketing, across all media, the ability to take meaningful action where transgressions are identified and an even playing field for all actors. - Gray is a senior lecturer at the University of KwaZulu-Natal and co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. This is the fourth of a new series of #InsideTheBox columns he is writing for Spotlight. Disclosure: Gray is a member of South Africa's National Essential Medicines List Committee and co-chairs its Expert Review Committee.
Yahoo
an hour ago
- Yahoo
Cannibal robot? Scientists develop a robot that can grow and heal by eating others
This robot is not the first transformer mechanism revealed to the public, but the way it transforms is certainly novel – it grows and heals by consuming other robots. Researchers from Columbia University in the United States have developed a robot, called the Truss Link, that can detect and merge with pieces of robots nearby to fill in missing parts. "True autonomy means robots must not only think for themselves but also physically sustain themselves," Philippe Martin Wyder, lead author and researcher at Columbia Engineering and the University of Washington, wrote in a statement. Related China unveils tiny spy drone that looks like a mosquito. What other small spy drones exist? Made with magnetic sticks, the Truss Link can expand or transform from a flat shape to a 3D structure to adapt to the environment. It can also add new bits from other robots or discard old parts that are not functional anymore to increase its performance. In a video posted by the team, the robot merges with a piece nearby and uses it as a walking stick to increase its speed by more than 50 per cent. Related This new artificial muscle can move just like human muscles but it's 17 times stronger 'Gives legs to AI' Researchers named the process in which the robot self-assembles bits of other robots 'robot metabolism'. It is described as a natural biological organism that can often absorb and integrate resources. Robots like the Truss Link can 'provide a digital interface to the physical world, and give legs to AI,' according to a video produced by Columbia Engineering School. Integrated with AI, they possess great potential, experts believe. "Robot metabolism provides a digital interface to the physical world and allows AI to not only advance cognitively, but physically – creating an entirely new dimension of autonomy," said Wyder. The Truss Link could, in future, be used to help develop groundbreaking technologies spanning from marine research to rescue services to extraterrestrial life. Related Stanford engineers have taken a leaf out of nature's book to build this bird robot "Ultimately, it opens up the potential for a world where AI can build physical structures or robots just as it, today, writes or rearranges the words in your email," Wyder said. Programming robots has been a challenge for engineers; however, artificial intelligence is advancing developments in robotics. 'We now have the technology [AI] to make robots really programmable in a general-purpose way and make it so that normal people can programme them, not just specific robot programming engineers," Rev Lebaredian, vice president of Omniverse and simulation technology at Nvidia, told Euronews Next in May.
Yahoo
3 hours ago
- Yahoo
The 5 Best Cereals to Reduce Stroke Risk, According to Cardiologists and Dietitians
Reviewed by Dietitian Maria Laura Haddad-Garcia Cardiovascular disease (CVD) and stroke are among the leading causes of death and disability in the United States. While genetics and lifestyle play a role, diet is a key player in stroke prevention—and your morning cereal can help tip the scales in your favor. "A high-fiber, low-sodium diet can help to promote optimal blood sugar, blood pressure and cholesterol levels, which can reduce the risk of plaque formation, hypertension, diabetes and stroke," says Bhavna Suri, M.D, a cardiologist. While breakfast cereals are a quick and easy choice, not all are made the same. Many are packed with added sugar and lack fiber—two strikes against stroke prevention. Instead, look for cereals that are low in added sugars and sodium, high in fiber and made with whole grains. Here are five of the best cereals, approved by heart-health experts, that can reduce your risk of stroke. Plus: tips on building a stroke-smart breakfast. 1. Shredded Wheat (Unfrosted) When it comes to heart-healthy cereals, Post Shredded Wheat Original Spoon Size® cereal stands out. "When looking for a cereal to reduce your stroke risks, generally, you are looking for one that is high in fiber and low in added sugar," says Abigail Nessle, RDN, LDN. This option checks those boxes, with one serving (1 ⅓ cup) providing 8 grams of fiber, which is 28% of the Daily Value. It also contains essential nutrients, including iron, niacin, phosphorus, magnesium and zinc. Magnesium, in particular, has been shown to protect against stroke risk (particularly in women), though more research is needed. Plus, Post Shredded Wheat is sodium-free—a big win for a heart-healthy diet. Most Americans consume significantly more sodium than the recommended daily intake of 2,300 mg per day, with average intake exceeding 3,000 mg. Reducing sodium intake can help lower your blood pressure and reduce your risk of cardiovascular disease and stroke. 2. Cascadian Farm Organic No Added Sugar Cereals Added sugars are a sneaky contributor to cardiovascular disease and stroke risk. Breakfast cereals are a common source of added sugar, even in those labeled as healthy due to their high fiber or whole grain content. Cascadian Farm Organic No Added Sugar offers a tasty solution. It comes in two flavors—Vanilla Crisp and Mixed Berry—so you have a choice to fit your preferences. Each 1 ¼-cup serving offers 5 g of protein and 5-6 (depending on the flavor) g of fiber—two nutrients that contribute to increased feelings of satiety. Plus: "One of the many superpowers of fiber is to help block the absorption of cholesterol that can turn into plaque in the veins and arteries," says Nessle. When cholesterol is elevated, blood flow can be blocked, resulting in a type of stroke called an ischemic stroke. One caveat: Both flavors are higher in sodium than what many dietitians recommend for a stroke-smart breakfast, with 390-400 mg per serving. Karen E. Todd, RD, CSCS, EP-C, CISSN, suggests choosing a cereal with less than 140 mg of sodium per serving. Modifying the portion size or reducing sodium in other meals can help keep your total daily intake within recommended limits. 3. Post Grape-Nuts The Original Upping your daily fiber is easy if you choose Post Grape-Nuts The Original as your morning cereal. Just one 1 ½-cup serving offers 7 g of fiber and zero added sugar, along with iron, folate, vitamin B6, niacin, thiamin, zinc and phosphorus. Some research suggests that folic acid supplementation may lower stroke risk, though supplements can have varied effects depending on individual health conditions. That's why food sources like Grape-Nuts are ideal for getting these nutrients. 4. Old-Fashioned Rolled Oats A classic for a reason, oats are a heart-healthy, high-fiber choice that makes a great addition to a stroke-smart breakfast. "Packed with 4-5 grams of fiber per ½ cup, [oats] lower cholesterol with beta-glucans and keep blood sugar steady,' says Todd. Beta-glucan, a component of soluble fiber found in oats, is especially beneficial for reducing cholesterol in the blood. Optimal dietary fiber intake also helps support a healthy weight, thereby reducing the risk of certain chronic diseases, such as cardiovascular disease. For added fiber and antioxidants, stir in chia seeds or top with fresh berries. 5. Bran Cereals Bran cereals are another fiber-rich pick, typically offering 5 to 7 g of fiber per serving. Many are also fortified with key vitamins and minerals, such as iron and vitamin D. Bran cereal may help manage blood pressure, cholesterol, and blood sugar—all critical factors in reducing the risk of cardiovascular disease. Just be sure to check the Nutrition Facts label—some brands sneak in more than 200 mg of sodium per serving. How to Build a Stroke-Smart Breakfast Building a stroke-smart breakfast means paying close attention to a few key nutrients. When choosing a morning cereal, Todd recommends avoiding those that are high in added sugar or sodium, as well as refined-grain cereals and instant oatmeal packets with added sugars. Here's how to round out your morning meal for better heart health: Add Fruits or Vegetables Potassium-rich foods, such as fruits and veggies, support heart health and are often missing from breakfast. "A 2023 review of more than 25 studies found that a diet rich in fruits and vegetables earlier in life may lower stroke risk compared with meat and fat intake," says Brittany Brown, RD, IBCLC, CDE. Try blending leafy greens like spinach into a smoothie or topping your bowl of cereal with fresh berries. Limit Sodium Some common breakfast choices—like breakfast meats, biscuits and some processed cereals—are high in sodium. "Diets high in salt can increase your blood pressure and risk of stroke," says Suri. Aim to stay under 2,300 mg of sodium daily (ideally closer to 1,500 mg) for heart protection. Cut Back on Added Sugar While added sugar is found in obvious foods like pastries, tarts and muffins, it often sneaks into less obvious ones as well. Be sure to check the nutrition facts label when looking for a breakfast option. And limiting sugar doesn't mean that you can't satisfy your sweet tooth; Todd recommends turning to naturally sweet foods like fruit and unsweetened dairy products. Incorporate Healthy Fats "Some cereals contain nuts and flax seeds, which can improve our levels of good HDL cholesterol," says Suri. Add in walnuts, almonds, chia or hemp seeds for more heart health benefits. Our Expert Take "Your plate is a powerful tool for stroke prevention," says Todd. And if you're choosing cereal, then your bowl is too. A breakfast cereal made from whole grains, with minimal sugar and sodium, can become a daily opportunity to protect your health—starting with your heart. Don't forget to boost your bowl with extras like fruit, seeds and nuts to enhance the fiber and nutrient profile. Read the original article on EATINGWELL
